The Journal of Immunology, Vol 145, Issue 8 2514-2519, Copyright © 1990 by American Association of Immunologists

ARTICLES

Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium

SM Wahl, JB Allen, HL Wong, SF Dougherty and LR Ellingsworth
Laboratory of Immunology, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.

We investigated potential mechanisms by which lymphocytes infiltrating rheumatoid synovium become immunosuppressed. In 20 of 22 synovial fluids and 12 of 13 synovial tissue culture supernatants, no IL-1 bioactivity could be detected in the thymocyte proliferation assay. These same preparations could, however, support proliferation of fibroblast monolayers, consistent with the presence of IL-1 and/or other fibroblast growth factors. Addition of either rheumatoid synovial fluids or synovial culture supernatants to exogenous IL-1 in the IL-1 bioassay caused marked inhibition of the assay indicative of an IL-1 inhibitor. This inhibition of IL-1 could be reversed by treating the effusions or supernatants with a neutralizing antibody to transforming growth factor-beta (TGF-beta). Furthermore, monocyte-macrophages isolated from rheumatoid synovial fluid constitutively released both latent and active TGF-beta in culture at levels sufficient to completely block the biologic activity of 100 U/ml IL-1. The production of substantial levels of TGF-beta by synovial macrophages, as well as the apparent ability of these inflammatory macrophages to activate latent TGF-beta, implicates TGF-beta not only as an important inhibitor of IL-1-induced lymphocyte proliferation, but also as a key cytokine in promoting synovial fibroblast hyperplasia and pathology.

This article has been cited by other articles:

				K. M. Stuhlmeier and C. Pollaschek Differential Effect of Transforming Growth Factor {beta} (TGF-{beta}) on the Genes Encoding Hyaluronan Synthases and Utilization of the p38 MAPK Pathway in TGF-{beta}-induced Hyaluronan Synthase 1 Activation J. Biol. Chem., March 5, 2004; 279(10): 8753 - 8760. [Abstract] [Full Text] [PDF]

				Y. Yamanishi, D. L. Boyle, M. Clark, R. A. Maki, M. D. Tortorella, E. C. Arner, and G. S. Firestein Expression and Regulation of Aggrecanase in Arthritis: The Role of TGF-{beta} J. Immunol., February 1, 2002; 168(3): 1405 - 1412. [Abstract] [Full Text] [PDF]

				B. T. Wipke and P. M. Allen Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis J. Immunol., August 1, 2001; 167(3): 1601 - 1608. [Abstract] [Full Text] [PDF]

				R. O. Sanchez Mejia, B. K. Lam, and J. P. Arm Matrix-Associated Transforming Growth Factor-beta 1 Primes Mouse Bone Marrow-Derived Mast Cells for Increased High-Affinity Fc Receptor for Immunoglobulin E-Dependent Eicosanoid Biosynthesis Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 557 - 565. [Abstract] [Full Text]

				N. S. Sampson, S. T. Ryan, D. A. Enke, D. Cosgrove, V. Koteliansky, and P. Gotwals Global Gene Expression Analysis Reveals a Role for the alpha 1 Integrin in Renal Pathogenesis J. Biol. Chem., August 31, 2001; 276(36): 34182 - 34188. [Abstract] [Full Text] [PDF]